Organovo

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Organovo and buy or sell other stocks, ETFs, and their options commission-free!

About ONVO

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. 

CEO
Taylor J. Crouch
CEOTaylor J. Crouch
Employees
6
Employees6
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2012
Founded2012
Employees
6
Employees6

ONVO Key Statistics

Market cap
410.14M
Market cap410.14M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
1.28M
Average volume1.28M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.93
52 Week high$0.93
52 Week low
$0.1933
52 Week low$0.1933
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.